Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations

This publication has 35 references indexed in Scilit:

• Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints
  Leukemia, 1998
• Association of CYP 3 A 4 genotype with treatment-related leukemia
  Proceedings of the National Academy of Sciences, 1998
• Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis
  Leukemia Research, 1997
• The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9
  Nature Genetics, 1996
• Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia
  Nature Genetics, 1996
• The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex
  Cell, 1995
• Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children: Case reports and review of the literature
  Cancer Genetics and Cytogenetics, 1994
• Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction
  Mutation Research/Environmental Mutagenesis and Related Subjects, 1994
• Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
  New England Journal of Medicine, 1989
• A consensus sequence for cleavage by vertebrate DNA topoisomerase II
  Nucleic Acids Research, 1988